Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, 229 Taibai North Road, Xi'an, 710069, China.
Key Laboratory of Molecular Mechanism and Intervention Research for Plateau Diseases of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, 712082, Shaanxi, China.
Pharmacogenomics J. 2021 Feb;21(1):60-68. doi: 10.1038/s41397-020-0177-y. Epub 2020 Jul 23.
Drug gene polymorphisms are strongly associated with disease. Previous studies have shown that the frequency of drug genes varies in different populations. At present, there are no reports about the polymorphism of the drug genome in the Zhuang population in southern China. This study conducted a pharmacogenomics study on the Zhuang population in southern China. Therefore, we conducted genotyping on 105 Zhuang samples, and compared the genotyping results with those of other 11 ethnic groups after statistical analysis. Our results show that, compared with the 11 populations in the HapMap data set, the differences between the CYP2E1 rs2070676 and CYP2D6 rs1065852 of the Zhuang nationality are the largest. This study fills in the blank of the drug genome information of the Zhuang nationality in southern China. The two sites of Rs2070676 (CYP2E1) and rs1065852 (CYP2D6) provide a reliable basis for the prediction of the efficacy of certain drugs. Its main purpose is to provide theoretical basis for safe drug use in the Zhuang region of southern China.
药物基因多态性与疾病密切相关。先前的研究表明,药物基因的频率在不同人群中存在差异。目前,关于中国南方壮族人群药物基因组的多态性尚无报道。本研究对中国南方壮族人群进行了药物基因组学研究。因此,我们对 105 例壮族样本进行了基因分型,并在统计分析后将基因分型结果与其他 11 个民族进行了比较。我们的结果表明,与 HapMap 数据集的 11 个群体相比,壮族 CYP2E1 rs2070676 和 CYP2D6 rs1065852 的基因分型结果差异最大。本研究填补了中国南方壮族药物基因组信息的空白。Rs2070676(CYP2E1)和 rs1065852(CYP2D6)这两个位点为某些药物疗效的预测提供了可靠的依据。其主要目的是为中国南方壮族地区安全用药提供理论依据。